Clinical Trial

A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-23
Trial Details
NCT Number NCT07433179
Lead Sponsor Septerna, Inc.
Conditions Healthy Volunteers
Enrollment 150 participants
Start Date 2026-03-04
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-22